The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Multiple sclerosis – a review
Open accessAbstract
Multiple sclerosis (MS) is the commonest non‐traumatic disabling disease to affect young adults. The incidence of MS is increasing worldwide, together with the socioeconomic impact of the disease. The underlying cause of MS and mechanisms behind this increase remain opaque, although complex gene–environment interactions almost certainly play a significant role. The epidemiology of MS indicates that low serum levels of vitamin D, smoking, childhood obesity and infection with the Epstein–Barr virus are likely to play a role in disease development. Changes in diagnostic methods and criteria mean that people with MS can be diagnosed increasingly early in their disease trajectory. Alongside this, treatments for MS have increased exponentially in number, efficacy and risk. There is now the possibility of a diagnosis of ‘pre‐symptomatic MS’ being made; as a result potentially preventive strategies could be studied. In this comprehensive review, MS epidemiology, potential aetiological factors and pathology are discussed, before moving on to clinical aspects of MS diagnosis and management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30470-2 · Cited by 8,167
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Defining the clinical course of multiple sclerosis: The 2013 revisions
Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., Thompson, A. J., Wolinsky, J. S., Balcer, L. J., Banwell, B., Barkhof, F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000560 · Cited by 3,177
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Montalban, X., Hauser, S. L., Kappos, L., Arnold, D. L., Bar-Or, A., Comi, G., de Seze, J., Giovannoni, G., Hartung, H.-P., Hemmer, B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606468 · Cited by 1,905
Self-citationThe relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International Multiple Sclerosis Genetics Consortium (IMSGC) (2013) · Nature Genetics · doi:10.1038/ng.2770 · Cited by 1,386
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
Browne, P., Chandraratna, D., Angood, C., Tremlett, H., Baker, C., Taylor, B. V., & Thompson, A. J. (2014) · Neurology · doi:10.1212/wnl.0000000000000768 · Cited by 1,223
The changing demographic pattern of multiple sclerosis epidemiology
Koch-Henriksen, N., & Sørensen, P. S. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70064-8 · Cited by 1,191
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,042
Sex ratio of multiple sclerosis in Canada: a longitudinal study
Orton, S.-M., Herrera, B. M., Yee, I. M., Valdar, W., Ramagopalan, S. V., Sadovnick, A. D., & Ebers, G. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70581-6 · Cited by 921
New insights into the burden and costs of multiple sclerosis in Europe
Kobelt, G., Thompson, A., Berg, J., Gannedahl, M., Eriksson, J., the MSCOI Study Group, & Platform, T. E. M. S. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517694432 · Cited by 733
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
Montalban, X., Gold, R., Thompson, A. J., Otero-Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comi, G., Derfuss, T., Fazekas, F., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517751049 · Cited by 712
Evidence for a two-stage disability progression in multiple sclerosis
Leray, E., Yaouanq, J., Le Page, E., Coustans, M., Laplaud, D., Oger, J., & Edan, G. (2010) · Brain · doi:10.1093/brain/awq076 · Cited by 596
A functional and structural basis for TCR cross-reactivity in multiple sclerosis
Lang, H. L. E., Jacobsen, H., Ikemizu, S., Andersson, C., Harlos, K., Madsen, L., Hjorth, P., Sondergaard, L., Svejgaard, A., Wucherpfennig, K., et al. (2002) · Nature Immunology · doi:10.1038/ni835 · Cited by 591
Multiple sclerosis: risk factors, prodromes, and potential causal pathways
Ramagopalan, S. V., Dobson, R., Meier, U. C., & Giovannoni, G. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70094-6 · Cited by 548
Coles, A. J., Cox, A., Page, E., Jones, J., Trip, S. A., Deans, J., Seaman, S., Miller, D. H., Hale, G., Waldmann, H., et al. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0934-5 · Cited by 506
Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis
Lundmark, F., Duvefelt, K., Iacobaeus, E., Kockum, I., Wallström, E., Khademi, M., Oturai, A., Ryder, L. P., Saarela, J., Harbo, H. F., et al. (2007) · Nature Genetics · doi:10.1038/ng2106 · Cited by 483
Immunopathology of secondary‐progressive multiple sclerosis
Prineas, J. W., Kwon, E. E., Cho, E., Sharer, L. R., Barnett, M. H., Oleszak, E. L., Hoffman, B., & Morgan, B. P. (2001) · Annals of Neurology · doi:10.1002/ana.1255 · Cited by 453
Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study
Mokry, L. E., Ross, S., Ahmad, O. S., Forgetta, V., Smith, G. D., Leong, A., Greenwood, C. M. T., Thanassoulis, G., & Richards, J. B. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001866 · Cited by 445
Vitamin D and Multiple Sclerosis: A Comprehensive Review
Sintzel, M. B., Rametta, M., & Reder, A. T. (2018) · Neurology and Therapy · doi:10.1007/s40120-017-0086-4 · Cited by 435
The immunogenetics of multiple sclerosis: A comprehensive review
Hollenbach, J. A., & Oksenberg, J. R. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.06.010 · Cited by 420
Class II HLA interactions modulate genetic risk for multiple sclerosis
the International Multiple Sclerosis Genetics Consortium (2015) · Nature Genetics · doi:10.1038/ng.3395 · Cited by 418
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Gregory, A. P., Dendrou, C. A., Attfield, K. E., Haghikia, A., Xifara, D. K., Butter, F., Poschmann, G., Kaur, G., Lambert, L., Leach, O. A., et al. (2012) · Nature · doi:10.1038/nature11307 · Cited by 384
Overexpression of the Cytokine BAFF and Autoimmunity Risk
Steri, M., Orrù, V., Idda, M. L., Pitzalis, M., Pala, M., Zara, I., Sidore, C., Faà, V., Floris, M., Deiana, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610528 · Cited by 382
Karussis, D. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.01.022 · Cited by 366
An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis
Handel, A. E., Williamson, A. J., Disanto, G., Handunnetthi, L., Giovannoni, G., & Ramagopalan, S. V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012496 · Cited by 343
Self-citationRadiologically isolated syndrome: 5-year risk for an initial clinical event
Okuda, D. T., Siva, A., Kantarci, O., Inglese, M., Katz, I., Tutuncu, M., Keegan, B. M., Donlon, S., Hua, L. H., Vidal-Jordana, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090509 · Cited by 339
Brain atrophy and lesion load predict long term disability in multiple sclerosis
Popescu, V., Agosta, F., Hulst, H. E., Sluimer, I. C., Knol, D. L., Sormani, M. P., Enzinger, C., Ropele, S., Alonso, J., Sastre-Garriga, J., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304094 · Cited by 331
Environmental factors in multiple sclerosis
Ascherio, A. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.865866 · Cited by 330
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis
Hedström, A. K., Bäärnhielm, M., Olsson, T., & Alfredsson, L. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b59c40 · Cited by 323
Smoking and Multiple Sclerosis: An Updated Meta-Analysis
Handel, A. E., Williamson, A. J., Disanto, G., Dobson, R., Giovannoni, G., & Ramagopalan, S. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016149 · Cited by 296
Self-citationLong-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
Muraro, P. A., Pasquini, M., Atkins, H. L., Bowen, J. D., Farge, D., Fassas, A., Freedman, M. S., Georges, G. E., Gualandi, F., Hamerschlak, N., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5867 · Cited by 275
Cortical lesions in multiple sclerosis
Calabrese, M., Filippi, M., & Gallo, P. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.93 · Cited by 269
B‐cell Therapy for Multiple Sclerosis: Entering an era
Greenfield, A. L., & Hauser, S. L. (2018) · Annals of Neurology · doi:10.1002/ana.25119 · Cited by 265
Obesity and Multiple Sclerosis: A Mendelian Randomization Study
Mokry, L. E., Ross, S., Timpson, N. J., Sawcer, S., Davey Smith, G., & Richards, J. B. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002053 · Cited by 263
Maier, L. M., Lowe, C. E., Cooper, J., Downes, K., Anderson, D. E., Severson, C., Clark, P. M., Healy, B., Walker, N., Aubin, C., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000322 · Cited by 245
Pathology and disease mechanisms in different stages of multiple sclerosis
Lassmann, H. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.05.010 · Cited by 224
Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk
Rhead, B., Bäärnhielm, M., Gianfrancesco, M., Mok, A., Shao, X., Quach, H., Shen, L., Schaefer, C., Link, J., Gyllenberg, A., et al. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000097 · Cited by 212
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes
Amato, M. P., Hakiki, B., Goretti, B., Rossi, F., Stromillo, M. L., Giorgio, A., Roscio, M., Ghezzi, A., Guidi, L., Bartolozzi, M. L., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31824528c9 · Cited by 209
Pakpoor, J., Disanto, G., Gerber, J. E., Dobson, R., Meier, U. C., Giovannoni, G., & Ramagopalan, S. V. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458512449682 · Cited by 177
Self-citationMultiple sclerosis in time and space--geographic clues to cause.
Kurtzke, J. F. (2000) · PubMed · Cited by 165
Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth
Aubert-Broche, B., Fonov, V., Narayanan, S., Arnold, D. L., Araújo, D., Fetco, D., Till, C., Sled, J. G., Banwell, B., Collins, D. L., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001045 · Cited by 151
Manousaki, D., Dudding, T., Haworth, S. J., Hsu, Y., Liu, C., Medina‐Gómez, C., Voortman, T., van der Velde, N., Melhus, H., Robinson‐Cohen, C., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.06.014 · Cited by 140
Waldman, A. T., Ness, J., Pohl, D., Simone, I. L., Anlar, B., Amato, M. P., & Ghezzi, A. (2016) · Neurology · doi:10.1212/wnl.0000000000003028 · Cited by 136
Giovannoni, G., Cutter, G., Sormani, M. P., Belachew, S. M., Hyde, R., Koendgen, H., Knappertz, V. A., Tomic, D., Leppert, D., Herndon, R. M., et al. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.01.007 · Cited by 118
Self-citationA clinical patho-anatomical study of clinically silent multiple sclerosis
Engell, T. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03811.x · Cited by 116
Persistence of Epstein-Barr Virus in Self-Reactive Memory B Cells
Tracy, S. I., Kakalacheva, K., Lünemann, J. D., Luzuriaga, K., Middeldorp, J. M., & Thorley‐Lawson, D. A. (2012) · Journal of Virology · doi:10.1128/jvi.01699-12 · Cited by 107
Worldwide prevalence of familial multiple sclerosis: A systematic review and meta-analysis
Harirchian, M. H., Fatehi, F., Sarraf, P., Honarvar, N. M., & Bitarafan, S. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.12.015 · Cited by 99
Tallantyre, E. C., Bo, L., Al-Rawashdeh, O., Owens, T., Polman, C. H., Lowe, J., & Evangelou, N. (2009) · Brain · doi:10.1093/brain/awp106 · Cited by 93
Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine
Pakpoor, J., Handel, A. E., Giovannoni, G., Dobson, R., & Ramagopalan, S. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045295 · Cited by 74
Self-citationGenome sequencing uncovers phenocopies in primary progressive multiple sclerosis
Jia, X., Madireddy, L., Caillier, S. J., Santaniello, A., Esposito, F., Comı, G., Stüve, O., Zhou, Y., Taylor, B. V., Kilpatrick, T. J., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25263 · Cited by 64
Vitkova, M., Gdovinova, Z., Rosenberger, J., Szilasiova, J., Nagyová, I., Mikula, P., Krokavcova, M., Groothoff, J. W., & van Dijk, J. P. (2014) · Disability and health journal · doi:10.1016/j.dhjo.2014.05.004 · Cited by 63
Napier, M., Poole, C., Satten, G. A., Ashley‐Koch, A. E., Marrie, R. A., & Williamson, D. (2014) · Archives of Environmental & Occupational Health · doi:10.1080/19338244.2014.937381 · Cited by 60
Epidemiology in multiple sclerosis: a pilgrim’s progress
Kurtzke, J. F. (2013) · Brain · doi:10.1093/brain/awt220 · Cited by 60
School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis
Sinay, V. J., Akly, M. P., Zanga, G., Ciardi, C., & Racosta, J. M. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514554054 · Cited by 54
A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study
Westerlind, H., Stawiarz, L., Fink, K., Hillert, J. A., & Manouchehrinia, A. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516643394 · Cited by 52
Advanced Structural and Functional Brain MRI in Multiple Sclerosis
Giorgio, A., & Stefano, N. D. (2016) · Seminars in Neurology · doi:10.1055/s-0036-1579737 · Cited by 30
Koch, M. W., Ilnytskyy, Y., Golubov, A., Metz, L. M., Yong, V. W., & Kovalchuk, O. (2018) · European Journal of Neurology · doi:10.1111/ene.13565 · Cited by 25
Cited by
Clinical applications of stem cell-derived exosomes
Tan, F., Li, X., Wang, Z., Li, J., Shahzad, K., & Zheng, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01704-0 · Cited by 708
Teleanu, R. I., Niculescu, A.-G., Roza, E., Vladâcenco, O., Grumezescu, A. M., & Teleanu, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115954 · Cited by 596
Immune cell regulation of glia during CNS injury and disease
Greenhalgh, A. D., David, S., & Bennett, F. C. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0263-9 · Cited by 396
Laíns, I., Wang, J. C., Cui, Y., Katz, R., Vingopoulos, F., Staurenghi, G., Vavvas, D. G., Miller, J. W., & Miller, J. B. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100951 · Cited by 324
The mutual interplay of gut microbiota, diet and human disease
Illiano, P., Brambilla, R., & Parolini, C. (2020) · The FEBS Journal · doi:10.1111/febs.15217 · Cited by 322
Metadata
- Authors
- Dobson, R., & Giovannoni, G.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2018-11-18
- Volume
- 26
- Issue
- 1
- Pages
- 27-40
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2896014118
- Cited by
- 2,148
- References
- 58
- FWCI
- 61.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.